O

OmniSeq

30 employees

OmniSeq offers physicians and their patients of the most actionable tumor-profiling information possible.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Molecular Testing
Oncology
Clinical Trials
Health Diagnostics
Health Care
Cancer Genomics
clinical decision support
Clinical Trial Access
Biopharma
Bioinformatics
Precision Medicine

Date founded

2015

Funding rounds raised

O

OmniSeq raised undisclosed on June 12, 2015

Investors: ROSWELL PARK CANCER INSTITUTE

FAQ